Figure 2 | Scientific Reports

Figure 2

From: In silico analysis reveals EP300 as a panCancer inhibitor of anti-tumor immune response via metabolic modulation

Figure 2

Correlation of gene mutation frequencies with TIME subtypes revealing EP300 mutation as significantly associated with an immune-activated TIME: Significant association of gene mutation frequencies with specific TIME subtypes for 9 genes of all HNSCC (A), 11 genes of HPV-negative HNSCC (B) and 8 genes of HPV-positive HNSCC. Mutations in TP53 and EP300 are found in all three groups.

Back to article page